David Coats co-founded Correlation Ventures to apply predictive analytics to venture investing. He previously invested in life sciences at Hamilton Biosciences, Windamere Ventures and Forge Medical Ventures, founded Spine Wave, and served on UroMed’s senior management team.

Unclaimed profile

David Coats co-founded Correlation Ventures to apply predictive analytics to venture investing. He previously invested in life sciences at Hamilton Biosciences, Windamere Ventures and Forge Medical Ventures, founded Spine Wave, and served on UroMed’s senior management team.

Career

David Coats studied at Princeton University (Biology) and Harvard University (MBA).

Managing Director and Co-Founder at Correlation Ventures until Present

Investing Announcements

Cosigns Received

Lorna Borenstein
First Cosign
When I call David, he calls me back no matter where he is.
Source
medium.com

Super Unicorns. The Only Path to Riches in U.S. Venture?

Coats examines entry prices and exit outcomes to explain why early investments can generate strong returns without a billion-dollar exit.

Open ↗
medium.com

AI and U.S. Venture Returns - Will History Repeat Itself?

Compares earlier software and biotech cycles with AI, emphasizing the difference between scientific progress and immediate commercial adoption.

Open ↗
medium.com

Venture Capital — We’re Still Not Normal

A 2023 analysis of venture outcomes, outlier returns and changing loss rates, with explicit methodology for the underlying dataset.

Open ↗

David's Collections

David's Lists

In these lists

Cosigns Given